MedTrace Logo

Yoga@Work Intervention to Reduce Work-related Stress Among Information Technology Workers

NCT04313517 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2020-03-19

No results posted yet for this study

Summary

Over the last several decades, occupational stress at workplace comprise a major burden. Office based work are more prone to sedentary lifestyle, postural issues, workplace stress, repetitive strain injury, poor employee health. Workplace wellness programs has been very feasible access to employees at their own convenience and need. Yoga@Work Program was developed to suit the need for information technology workers.

Conditions

  • Occupational Stress
  • Psychological Stress

Interventions

OTHER

Yoga

Each yoga session included warm-up practices (for the large joints, spine, and extremities), Simple postures (Asana), breathing exercises (pranayama) and meditation/relaxation. All the yoga participants were given handouts to practice everyday at work as its feasible

Sponsors & Collaborators

  • Brunel University

    collaborator OTHER

  • NMP Medical Research Institute

    collaborator OTHER

  • Ananda Yoga (Hong Kong)

    collaborator UNKNOWN

  • Vrije Universiteit Brussel

    collaborator OTHER

  • Aarogyam UK

    lead OTHER

Principal Investigators

  • Neha Sharma, PhD · Aarogyam UK

  • Jaydeep Joshi, BAMS · Aarogyam UK

  • Monomita Nandy · Brunel University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-12
Primary Completion
2019-06-18
Completion
2019-09-21

Countries

  • Belgium
  • Hong Kong
  • India
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04313517 on ClinicalTrials.gov